First pediatric electronic algorithm to stratify risk of penicillin allergy

Area of Science:

• Pediatric Allergy and Immunology
• Clinical Informatics
• Drug Safety

Background:

• Beta-lactam allergy is frequently reported in children, yet most are not truly allergic upon specialist evaluation.
• Current diagnostic methods like skin testing for penicillin allergy are being re-evaluated for their utility in pediatrics.
• Oral drug challenges are considered the gold standard for ruling out immediate IgE-mediated drug allergies.

Discussion:

• This study validates a penicillin allergy stratification tool using both paper and electronic clinical algorithms in a pediatric cohort.
• An electronic algorithm successfully identified 61 low-risk patients (out of 95 deemed not allergic by experts) with no false negatives.
• The electronic algorithm proved superior to the paper version, identifying a higher percentage of low-risk patients.

Key Insights:

• An electronic algorithm accurately assesses penicillin allergy risk based on patient history, negating the need for diagnostic testing or allergist consultation.
• This tool empowers non-allergist healthcare professionals to safely de-label low-risk pediatric patients.
• The electronic approach significantly reduces reliance on allergist assessments, potentially decreasing wait times.

Outlook:

• Further implementation of electronic allergy assessment tools can streamline pediatric allergy evaluations.
• Wider adoption may improve healthcare resource allocation by reducing unnecessary specialist referrals.
• This approach supports evidence-based de-labeling of penicillin allergy in pediatric populations.